BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical


Collaborations

Metabasis Therapeutics, Inc.  – Hepatitis B





 Company News
Meda AB (MEDA-A.ST), Valeant Pharmaceuticals International (VRX) Terminate Joint Ventures 4/7/2014 7:02:43 AM    More...
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014 6:50:25 AM    More...
Valeant Pharmaceuticals International (VRX) CEO Eyes Corporate "Fat" In Push For Big Leagues 3/20/2014 8:28:02 AM    More...
Valeant Pharmaceuticals International (VRX) Donates $250,000 To The National Coalition Against Domestic Violence 3/6/2014 10:27:51 AM    More...
Valeant Pharmaceuticals International (VRX) Swings To Profit On Bausch & Lomb Buy 2/27/2014 7:44:21 AM    More...
Valeant Pharmaceuticals International (VRX) Reports Fourth Quarter And Full Year 2013 Financial Results 2/27/2014 6:36:37 AM    More...
Actavis (ACT) May Not Have It In The Bag, Valeant Pharmaceuticals International (VRX), Other Suitors Eye Forest Laboratories, Inc. (FRX) 2/20/2014 7:39:21 AM    More...
Valeant Pharmaceuticals International (VRX) To Announce 2013 Fourth Quarter And Full Year Results On February 27, 2014 2/6/2014 6:18:03 AM    More...
Valeant Pharmaceuticals International (VRX) Scoops Up Precision Dermatology For $475 Million Cash 2/3/2014 6:40:55 AM    More...
Valeant Pharmaceuticals International (VRX) Announces Approval Of Retin-A Micro® Microsphere 0.08% 1/31/2014 6:51:13 AM    More...
12345678910...